Chemed Corporation
CHE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 7.4% | 6.1% | -0.2% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 35.1% | 35.3% | 35.8% | 36% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 15.1% | 15% | 16.1% | 16% |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 12.4% | 12% | 11.7% | 12.6% |
| EPS | 20.1 | 18.11 | 16.72 | 17.14 |
| % Growth | 11% | 8.3% | -2.5% | – |
| EPS Diluted | 19.89 | 17.93 | 16.53 | 16.85 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 19.1% | 18.3% | 18.4% | 19.2% |